32670606
2020 May 27
As cancer management evolves into precision medicine national/international cancer meetings bring novel therapeutic approaches and potentially practice-changing results of clinical studies are presented. This year, the ASCO GI Symposium 2020 had also several updates from ongoing and finalized clinical trials. Although there were no groundbreaking results that impact the daily practice directly, several highly important data from ongoing studies were shared with the audience. In this report, the highlights of the ASCO GI Symposium 2020 are presented with a future perspective.
IDH mutations; cholangiocarcinoma; colorectal cancer; gastric cancer; gastrointestinal cancers; hepatocellular carcinoma; immunotherapy; pancreatic cancer; precision medicine.
